Home
Search
Placeholder Banner

Former BIO Board of Directors Chairs

Jeremy Levin
Jeremy M. Levin, DPhil, MB BChir

Jeremy M. Levin, DPhil, MB BChir, Chief Executive Officer of Ovid Therapeutics, is the Chair of BIO's Board of Directors for the 2019-2020 and 2020-2021 term.

Past Chairpersons of BIO

BIO recognized the significant contributions of the organization's former chairpersons, industry leaders who have volunteered their time for the betterment of the biotech sector and science.

John Maraganore
John Maraganore
Alnylam Pharmaceuticals
Chair 2017-2019
Ron Cohen
Ron Cohen
Acorda Therapeutics
Chair 2015-2017
Rachel King
Rachel King
GlycoMimetics
Chair 2013-2015
Tom Watkins
Tom Watkins
Human Genome Sciences
Chair 2011-2013
Stephen Sherwin
Stephen Sherwin
Ceregene
Chair 2009-2011
Joshua Boger
Joshua Boger
Vertex
Chair 2007-2009
James Mullen
James Mullen
Biogen
Chair 2005-2007
Richard Pops
Richard Pops
Alkermes
Chair 2003-2005
David Robinson
David E. Robinson
Ligand Pharmaceuticals, Inc.
Chair 2002-2003
David Anstice
David W. Anstice
Merck
Schering-Plough
Chair 2001-2002
Mark Skaletsky
Mark Skaletsky
GelTex Pharmaceuticals
Essential Therapeutics
Chair 2000-2001
Gordon Binder
Gordon M. Binder
Amgen
Chair 1998-2000
Henri Termeer
Henri Termeer
Genzyme
Chair 1996-1998
Kirk Raab
Kirk Raab
Genentech
Chair 1994-1996